Sermon by Bishop Jack Lumanog – “Let Us Go Over to the Other Side” part 1

Jack Lumanog

Bishop Jack Lumanog preaching at The Anglican Church of the Messiah, Plainfield New Jersey on 23 June 2024, where Archdeacon Gideon Uzomechina faithfully serves as the Rector.

Here is a video excerpt from Bishop Lumanog’s sermon from Mark 4:35-41 sermon “Let Us Go Over to the Other Side!”

Mark 4:35-41, ESV:
35 On that day, when evening had come, he said to them, “Let us go across to the other side.” 36 And leaving the crowd, they took him with them in the boat, just as he was. And other boats were with him. 37 And a great windstorm arose, and the waves were breaking into the boat, so that the boat was already filling. 38 But he was in the stern, asleep on the cushion. And they woke him and said to him, “Teacher, do you not care that we are perishing?” 39 And he awoke and rebuked the wind and said to the sea, “Peace! Be still!” And the wind ceased, and there was a great calm. 40 He said to them, “Why are you so afraid? Have you still no faith?” 41 And they were filled with great fear and said to one another, “Who then is this, that even the wind and the sea obey him?”

The Right Rev. Dr. Jon I. “Jack” Lumanog is an Anglican Bishop in good standing with the Apostolic Communion of Anglican Churches and the leader of The Anglican Diocese of St. Ignatius Loyola, overseeing clergy and congregations in the United States, South Asia, Africa and Southeast Asia. A pastor and evangelist at heart, Dr. Jack Lumanog has planted, revitalized and led churches, traveling extensively around the world to share the life-changing message of Jesus Christ. He served as a denominational leader for eight years, providing executive-level oversight for more than 1,000 congregations in the United States, Canada, and Mexico.

Dr. Lumanog is currently pursuing post-graduate studies in Management at Harvard University through the Harvard Extension School. He is an accomplished corporate strategist with extensive experience leading high-impact clinical projects for a Fortune 20 healthcare company.